Titan Biotech Limited (BOM:524717)

Titan Biotech Revenue

In the fiscal year ending March 31, 2026, Titan Biotech had annual revenue of 2.06B INR with 31.79% growth. Titan Biotech had revenue of 488.34M in the quarter ending March 31, 2026, with 38.85% growth.

• Revenue: 2.06B
• Revenue Growth: +31.79%
• P/S Ratio: 8.70
• Revenue / Employee: 4.42M
• Employees: 467
• Market Cap: 17.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.06B	497.40M	31.79%
Mar 31, 2025	1.56B	-76.21M	-4.65%
Mar 31, 2024	1.64B	200.73M	13.94%
Mar 31, 2023	1.44B	204.50M	16.55%
Mar 31, 2022	1.24B	-186.92M	-13.14%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error